Current Edition

Respiratory Network for Early-phase Clinical Trials

The biopharmaceutical industry has a growing need for early-phase clinical studies in respiratory patients to support more advanced and informed “go/no-go” decisions in drug development, enabling more efficient and productive future planning. Robert Lins at SGS writes on how on-site execution is often complex, requiring a focused and highly trained team of site staff.